Cytokines, granulocyte-monocyte colony stimulating factor, interleukin-3 and erythropoietin: Can be a therapeutic option for the stimulation of hematopoietic progenitor cells in trauma-hemorrhagic shock?

Podobne zapisy

• Impaired hematopoietic progenitor cells in trauma hemorrhagic shock
  od: Kumar, Manoj, i wsp.
  Wydane: (2016)
• Hematopoietic stem cells: Can it be a therapeutic option for the hematopoietic failure in patients with trauma-hemorrhagic shock?
  od: Kumar, Manoj, i wsp.
  Wydane: (2016)
• Does erythropoietin reactivate bone marrow dysfunction in trauma hemorrhagic shock?
  od: Kumar, Manoj, i wsp.
  Wydane: (2015)
• Human-induced pluripotent stem cells derived hematopoietic progenitor cells for treatment of hematopoietic failure among trauma hemorrhagic shock patients
  od: Kumar, Manoj, i wsp.
  Wydane: (2019)
• Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes.
  od: Hamilton, J A, i wsp.
  Wydane: (1992)